Your browser doesn't support javascript.
loading
Neuroprotection in Cerebral Cortex Induced by the Pregnancy Hormone Estriol.
Meyer, Cassandra E; Smith, Andrew W; Padilla-Requerey, Aitana A; Farkhondeh, Vista; Itoh, Noriko; Itoh, Yuichiro; Gao, Josephine L; Herbig, Patrick D; Nguyen, Quynhanh; Ngo, Katelyn H; Oberoi, Mandavi R; Siddarth, Prabha; Voskuhl, Rhonda R; MacKenzie-Graham, Allan.
  • Meyer CE; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Smith AW; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Padilla-Requerey AA; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Farkhondeh V; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Itoh N; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Itoh Y; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Gao JL; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Herbig PD; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Nguyen Q; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Ngo KH; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Oberoi MR; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
  • Siddarth P; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California.
  • Voskuhl RR; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • MacKenzie-Graham A; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, David Geffen School of Medicine at the University of California, Los Angeles, California; UCLA Multiple Sclerosis Program, Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Californi
Lab Invest ; 103(8): 100189, 2023 08.
Article en En | MEDLINE | ID: mdl-37245852

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Encefalomielitis Autoinmune Experimental / Esclerosis Múltiple Límite: Animals / Pregnancy Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Encefalomielitis Autoinmune Experimental / Esclerosis Múltiple Límite: Animals / Pregnancy Idioma: En Año: 2023 Tipo del documento: Article